Mitomycin C in Corneal Refractive Surgery

Survey of Ophthalmology

Volumn 54, Issue 4, 2009, Pages 487-502

  Teus, Miguel A ^a,b   de Benito Llopis, Laura ^a   Alió, Jorge L ^a,c  

^a VISSUM Corporacion Oftalmologica   (Spain)

^b UNIVERSITY OF ALCALÁ   (Spain)

^c MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

Author keywords

advanced surface ablation; excimer laser surface ablation; haze; LASEK; laser subepithelial keratomileusis; laser assisted subepithelial keratectomy mitomycin; mitomycin C; MMC; photorefractive keratectomy

Indexed keywords

MITOMYCIN C;

ANTIANGIOGENIC ACTIVITY; APOPTOSIS; ARTICLE; CELL DENSITY; CELL POPULATION; CILIARY BODY; CLINICAL TRIAL; CORNEA DISEASE; CORNEA ENDOTHELIUM; CORNEA STROMA; CYTOTOXICITY; ENDOTHELIUM INJURY; EYE TOXICITY; FOLLOW UP; HUMAN; INTRAOCULAR PRESSURE; LASER SURGERY; MYOFIBROBLAST; MYOPIA; NONHUMAN; PRIORITY JOURNAL; REFRACTIVE SURGERY; RISK REDUCTION; TISSUE NECROSIS; TREATMENT INDICATION;

ALKYLATING AGENTS; ANIMALS; CORNEA; CORNEAL OPACITY; CORNEAL SURGERY, LASER; HUMANS; MITOMYCIN; POSTOPERATIVE COMPLICATIONS;

EID: 66949150579     PISSN: 00396257     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.survophthal.2009.04.002     Document Type: Article

References (169)

1. Alió J.L., Muftuoglu O., Ortiz D., et al. Ten-year follow-up of photorefractive keratectomy for myopia of less than -6 diopters. Am J Ophthalmol 145 (2008) 29-36
2. Alió J.L., Muftuoglu O., Ortiz D., et al. Ten-year follow-up of photorefractive keratectomy for myopia of more than -6 diopters. Am J Ophthalmol 145 (2008) 37-45
3. Anand N., Arora S., and Clowes M. Mitomycin C augmented glaucoma surgery: evolution of filtering bleb avascularity, transconjunctival oozing and leaks. Br J Ophthalmol 92 (2006) 175-180
4. Argento C., Cosentino M.J., and Ganly M. Comparison of laser epithelial keratomileusis with and without the use of mitomycin C. J Refract Surg 22 (2006) 782-786
5. Autrata R., and Rehurek J. Laser-assisted subepithelial keratectomy and pohotorefractive keratectomy for the correction of hyperopia: results of a 2-year follow-up. J Cataract Refract Surg 29 (2003) 2105-2114
6. Azar D.T., Tuli S., Benson R.A., and Hardten D.R. Photorefractive keratectomy for residual myopia after radial keratotomy. PRK after RK Study Group. J Cataract Refract Surg 24 (1998) 303-311
7. Baldwin H.C., and Marshall J. Growth factors in corneal wound healing following refractive surgery: a review. Acta Ophthalmol Scand 80 (2002) 238-247
8. Bedei A., Marabotti A., Giannecchini I., et al. Photorefractive keratectomy in high myopic defects with or without intraoperative mitomycin C: 1-year results. Eur J Ophthalmol 16 (2006) 229-234
9. Beerthuizen J.J.G., and Siebelt E. Surface ablation after laser in situ keratomileusis: retreatment on the flap. J Cataract Refract Surg 33 (2007) 1376-1380
10. Bligh H.F., Bartoszek A., Robson C.N., et al. Activation of mitomycin C by NADPH:cytochrome p-450 reductase. Cancer Res 50 (1990) 7789-7792
11. Cagil N., Aydin B., Ozturk S., and Hasiripi H. Effectiveness of laser-assisted subepithelial keratectomy to treat residual refractive errors after laser in situ keratomileusis. J Cataract Refract Surg 33 (2007) 642-647
12. Camellin M. Laser epithelial keratomileusis with mitomycin C: indications and limits. J Refract Surg 20 (2004) S693-S698
13. Carones F., Fiore T., and Brancato R. Mechanical vs alcohol epithelial removal during photorefractive keratectomy. J Refract Surg 15 (1999) 556-562
14. Carones F., Vigo L., Carones A., and Brancato R. Evaluation of photorefractive keratectomy retreatments after regressed myopic laser in situ keratomileusis. Ophthalmology 108 (2001) 1732-1737
15. Carones F., Vigo L., Scandola E., and Vacchini L. Evaluation of the prophylactic use of mitomycin-C to inhibit haze formation after photorefractive keratectomy. J Cataract Refract Surg 28 (2002) 2088-2095
16. Chabner B.A., Ryan D.P., Paz-Ares L., et al. Antineoplastic agents, in Hardman JG, Limbrid LE, Goodman Gilman A. The Pharmacological Basis of Therapeutics (2001), McGraw Hill, New York ed 10; pp 1389-459
17. Chalita M.R., Roth A.S., and Krueger R.R. Wavefront-guided surface ablation with prophylactic use of mitomycin C after a buttonhole laser in situ keratomileusis flap. J Refract Surg 20 (2004) 176-181
18. Chang S.W., Chou S.F., and Chuang J.L. Mechanical corneal epithelium scraping and ethanol treatment up-regulate cytokine gene expression differently in rabbit cornea. J Refract Surg 24 (2008) 150-159
19. Chang S.W., Chou S.F., and Chuang J.L. Mitomycin C potentiates ultraviolet-related cytotoxicity in corneal fibroblasts. Cornea 27 (2008) 686-692
20. Chang S.W. Corneal keratocyte apoptosis following topical intraoperative mitomycin C in rabbits. J Refract Surg 21 (2005) 446-453
21. Chang S.W. Early corneal edema following topical application of mitomycin-C. J Cataract Refract Surg 30 (2004) 1742-1750
22. Chen W.L., Chang H.W., and Hu F.R. In vivo confocal microscopic evaluation of corneal wound healing after epi-LASIK. Invest Ophthalmol Vis Sci 49 (2008) 2416-2423
23. Chou S.F., Chang S.W., and Chuang J.L. Mitomycin C upregulates IL-8 y MCP-1 chemokine expression via mitogen-activated protein kinases in corneal fibroblasts. Invest Ophthalmol Vis Sci 48 (2007) 2009-2016
24. Crowston J.G., Chang L.H., Constable P.H., et al. Apoptosis gene expression and death receptor signalling in mitomycin-C-treated human tenon capsule fibroblasts. Invest Ophthalmol Vis Sci 43 (2002) 692-699
25. Crowston J.G., Chang L.H., Daniels J.T., et al. T lymphocyte mediated lysis of mitomycin C treated Tenon's capsule fibroblasts. Br J Ophthalmol 88 (2004) 399-405
26. Cummings J., Spanswick V.J., Tomasz M., and Smyth J.F. Enzymology of mitomycin C metabolic activation in tumour tissue: implications for enzyme-directed bioreductive drug development. Biochem Pharmacol 56 (1998) 405-414
27. Daniels J.T., Occleston N.L., Crowston J.G., and Khaw P.T. Effects of antimetabolite induced cellular growth arrest on fibroblast-fibroblast interactions. Exp Eye Res 69 (1999) 117-127
28. Dawson D.G., Edelhauser H.F., and Grossniklaus H.E. Long-term histopathologic findings in human corneal wounds after refractive surgical procedures. Am J Ophthalmol 139 (2005) 168-178
29. De Benito-Llopis L., Teus M., Sánchez-Pina J.M., and Hernández-Verdejo J.L. Comparison between LASEK and LASIK for the correction of low myopia. J Refract Surg 23 (2007) 139-145
30. De Benito-Llopis L., Teus M.A., and Ortega M. Effect of mitomycin C on the corneal endothelium during excimer laser surface ablation. J Cataract Refract Surg 33 (2007) 1009-1013
31. De Benito-Llopis L., Teus M.A., Sánchez-Pina J.M., and Fuentes I. Stability of LASEK with and without mitomycin-C performed to correct myopia in thin corneas. A 15-month follow-up. Am J Ophthalmol 145 (2008) 807-812
32. De Benito-Llopis L., Teus M.A., and Sánchez-Pina J.M. Comparison between LASEK with MMC and LASIK for the correction of high myopia (-7.00 to -13.75 D). J Refract Surg 24 (2008) 516-523
33. Diakonis V.F., Pallikaris A., Kymionis G.D., and Markomanolakis M.M. Alterations in endothelial cell density after photorefractive keratectomy with adjuvant mitomycin. Am J Ophthalmol 144 (2007) 99-103
34. Dillon E.C., Eagle Jr. R.C., and Laibson P.R. Compensatory epithelial hyperplasia in human corneal disease. Ophthalmic Surg 23 11 (1992) 729-732
35. Dougherty P.J., Hardten D.R., and Lindstrom R.L. Corneoscleral melt after pterygium surgery using a single intraoperative application of mitomycin-C. Cornea 15 (1996) 537-540
36. Dupps W.J., and Wilson S.E. Biomechanics and wound healing in the cornea. Exp Eye Res 83 (2006) 709-720
37. Erie J.C., Patel S.V., McLaren J.W., et al. Corneal keratocyte deficits after photorefractive keratectomy and laser in situ keratomileusis. Am J Opththalmol 141 (2006) 799-809
38. Erie J.C., Patel S.V., McLaren J.W., et al. Keratocyte density in the human cornea after photorefractive keratectomy. Arch Ophthalmol 121 (2003) 770-776
39. Frueh B.E., Cadez R., and Bohnke M. In vivo confocal microscopy after photorefractive keratectomy in humans. A prospective, long-term study. Arch Ophthalmol 116 (1998) 1425-1431
40. Fujitani A., Hayasaka S., Shibuya Y., and Noda S. Corneoscleral ulceration and corneal perforation after pterygium excision and topical mitomycin-C therapy. Ophthalmologica 207 (1993) 162-164
41. Gabler B., von Mohrenfels C.W., Herrmann W., et al. Laser-assisted subepithelial keratectomy enhancement of residual myopia after primary myopic LASEK: six-month results in 10 eyes. J Cataract Refract Surg 29 (2003) 1260-1266
42. Gambato C., Ghirlando A., Moretto E., et al. Mitomycin C modulation of corneal wound healing after photorefractive keratectomy in highly myopic eyes. Ophthalmology 112 (2005) 208-219
43. Garweg J.G., Wegmann-Burns M., and Goldblum D. Effects of daunorubicin, mitomycin C, azathioprine and cyclosporine A on human retinal pigmented epithelial, corneal endothelial and conjunctival cell lines. Graefe's Arch Clin Exp Ophthalmol 244 (2006) 382-389
44. Gatinel D., Racine L., and Hoang-Xuan T. Contribution of the corneal epithelium to anterior corneal topography in patients having myopic photorefractive keratectomy. J Cataract Refract Surg 33 (2007) 1860-1865
45. Gauthier C.A., Holden B.A., Epstein D., et al. Factors affecting epithelial hyperplasia after photorefractive keratectomy. J Cataract Refract Surg 23 (1997) 1042-1050
46. Gimbel H.V., and Stoll S.B. Photorefractive keratectomy with customized segmental ablation to correct irregular astigmatism after laser in situ keratomileusis. J Refract Surg 17 (2001) S229-S232
47. Gipson I.K. Corneal epithelial and stromal reactions to excimer laser photorefractive keratectomy. I. Concerns regarding the response of the corneal epithelium to excimer laser ablation. Arch Ophthalmol 108 11 (1990) 1539-1540
48. Goeptar A.R., Groot E.J., Scheerens H., et al. Cytotoxicity of mitomycin C and adriamycin in freshly isolated rat hepatocytes: the role of cytochrome p450. Cancer Res 54 (1994) 2411-2418
49. Goldsberry D.H., Epstein R.J., Majmudar P.A., et al. Effect of mitomycin C on the corneal endothelium when used for corneal subepithelial haze prophylaxis following photorefractive keratectomy. J Refract Surg 23 (2007) 724-727
50. Hamberg-Nystrom H., Gauthier C.A., Holden B.A., et al. A comparative study of epithelial hyperplasia after PRK: Summit versus VISX in the same patient. Acta Ophthalmol Scand 74 3 (1996) 228-231
51. Haw W.W., and Manche E.E. Excimer laser retreatment of residual myopia following photoastigmatic refractive keratectomy for compound myopic astigmatism. J Cataract Refract Surg 26 (2000) 660-667
52. Heaps R.S., Nordlund J.R., Gonzalez-Fernandez F., et al. Ultrastructural changes in rabbit ciliary body after extraocular mitomycin C. Invest Ophthalmol Vis Sci 39 (1998) 1971-1975
53. Hernández-Galilea E., Sanchez F., Guzman K., et al. Effect of mitomycin C on corneal endothelium cells. In vitro study. Arch Soc Esp Oftalmol 75 (2000) 515-521
54. Herrman W.A., Muecke M., Koller M., et al. Keratocyte density in the retroablation area after LASEK for the correction of myopia. Graefe's Arch Clin Exp Ophthalmol 245 (2007) 426-430
55. Isager P., Hjortdal J.O., and Ehlers N. Magnification changes in specular microscopy after corneal refractive surgery. Acta Ophthalmol Scand 77 (1999) 391-393
56. Islaih M., Halstead B.W., Kadura I.A., et al. Relationships between genomic, cell cycle, and mutagenic responses of TK6 cells exposed to DNA damaging chemicals. Mutat Res 578 (2005) 100-116
57. Jain S., McCally R.L., Connolly P.J., and Azar D.T. Mitomycin C reduces corneal light scattering after excimer keratectomy. Cornea 20 (2001) 45-49
58. Jester J.V., and Ho-Chang J. Modulation of cultured corneal keratocyte phenotype by growth factors /cytokines control in vitro contractility and extracellular matrix contraction. Exp Eye Res 77 (2003) 581-592
59. Jester J.V., Petroll W.M., and Cavanagh H.D. Corneal stromal wound healing in refractive surgery: the role of myofibroblasts. Prog Retin Eye Res 18 (1999) 311-356
60. Joyce N.C., Navon S.E., Roy S., and Zieske J.D. Expression of cell cycle-associated proteins in human and rabbit corneal endothelium in situ. Invest Ophthalmol Vis Sci 37 (1996) 1566-1575
61. Joyce N.C. Cell cycle status in human corneal endothelium. Exp Eye Res 81 (2005) 629-638
62. Joyce N.C. Proliferative capacity of the corneal endothelium. Prog Ret Eye Res 22 (2003) 359-389
63. Khaw P.T., Doyle J.W., Sherwood M.B., et al. Prolonged localized tissue effects from 5-minute exposures to fluorouracil and mitomycin C. Arch Ophthalmol 111 (1993) 263-267
64. Khong J.J., and Muecke J. Complications of mitomycin C therapy in 100 eyes with ocular surface neoplasia. Br J Ophthalmol 90 (2006) 819-822
65. Khoury J.M., Farah T., El-Haibi C.P., and Noureddin B.N. Corneal light shield as a delivery system for standardized application of mitomycin C in excimer surface ablation. J Refract Surg 23 (2007) 716-719
66. Kim J.K., Kim S.S., Lee H.K., et al. Laser in situ keratomileusis versus laser-assisted subepithelial keratectomy for the correction of high myopia. J Cataract Refract Surg 30 (2004) 1405-1411
67. Kim T.I., Lee S.Y., Pak J.H., et al. Mitomycin C, ceramide, and 5-fluorouracil inhibit corneal haze and apoptosis after PRK. Cornea 25 (2006) 55-60
68. Kim T.I., Pak J.H., Lee S.Y., and Tchah H. Mitomycin C-induced reduction of keratocytes and fibroblasts after photorefractive keratectomy. Invest Ophthalmol Vis Sci 45 (2004) 2978-2984
69. Kim T.I., Tchah H., Cho E.H., and Kook M.S. Evaluation for safety of cultured corneal fibroblasts with cotreatment of alcohol and mitomycin C. Invest Ophthalmol Vis Sci 45 (2004) 86-92
70. Kim T.I., Tchah H., Lee S.A., et al. Apoptosis in keratocytes caused by mitomycin C. Invest Ophthalmol Vis Sci 44 (2003) 1912-1917
71. Kremer I., Kaplan A., Novikov I., and Blumenthal M. Patterns of late corneal scarring after photorefractive keratectomy in high and severe myopia. Ophthalmology 106 (1999) 467-473
72. Kymionis G.D., Diakonis V.F., Charisis S., et al. Effects of topical mitomycin C on the ciliary body and intraocular pressure after PRK: an experimental study. J Refract Surg 24 (2008) 633-638
73. Kymionis G.D., Tsiklis N.S., Ginis H., et al. Dry eye after photorefractive keratectomy with adjuvant mitomycin C. J Refract Surg 22 (2006) 511-513
74. La Tegola M.G., Alessio G., and Sborgia C. Topographic customized photorefractive keratectomy for regular and irregular astigmatism after penetrating keratoplasty using the LIGI CIPTA/LaserSight Platform. J Refract Surg 23 (2007) 681-693
75. Lacayo III G.O., and Majmudar P.A. How and when to use mitomycin-C in refractive surgery. Curr Opin Ophthalmol 16 (2005) 256-259
76. Lai Y.H., Wang H.Z., Lin C.P., and Chang S.J. Mitomycin C alters corneal stromal wound healing and corneal haze in rabbits after argon-fluoride excimer laser photorefractive keratectomy. J Ocul Pharmacol Ther 20 (2004) 129-138
77. Lane H.A., Swale J.A., and Majmudar P.A. Prophylactic use of mitomycin-C in the management of a buttonholed LASIK flap. J Cataract Refract Surg 29 (2003) 390-392
78. Laube T., Wissing S., Tehis C., et al. Decreased keratocyte death after laser-assisted subepithelial keratectomy and photorefractive keratectomy in rabbits. J Cataract Refract Surg 30 (2004) 1998-2004
79. Leccisotti A. Mitomycin C in photorefractive keratectomy: effect on epithelialization and predictability. Cornea 27 (2008) 288-291
80. Lee D.H., Chung H.S., Jeon Y., et al. Photorefractive keratectomy with intraoperative mitomycin-C application. J Cataract Refract Surg 31 (2005) 2293-2298
81. Lee Y.J., Park S.J., Ciccone S.L., et al. An in vivo analysis of MMC-induced DNA damage and its repair. Carcinogenesis 27 (2006) 446-453
82. Legeais J.M., Mayer F., Saragoussi J.J., et al. The optical power of the corneal epithelium In vivo evaluation. J Fr Ophtalmol 20 3 (1997) 207-212
83. Lin N., Yee S.B., Mitra S., et al. Prediction of corneal haze using an ablation depth/corneal thickness ratio after laser epithelial keratomileusis. J Refract Surg 20 (2004) 797-802
84. Lohmann C.P., Reischl U., and Marshall J. Regression and epithelial hyperplasia after myopic photorefractive keratectomy in a human cornea. J Cataract Refract Surg 25 (1999) 712-715
85. Majmudar P.A., Forstot S.L., Dennis R.F., et al. Topical mitomycin C for subepithelial fibrosis after refractive corneal surgery. Ophthalmology 107 (2000) 89-94
86. Maldonado M.J. Intraoperative MMC after excimer laser surgery for myopia. Ophthalmology 109 (2002) 826-828
87. Maloney R.K., Chan W.K., Steinert R., et al. A multicenter trial of photorefractive keratectomy for residual myopia after previous ocular surgery. Summit Therapeutic Refractive Study Group. Ophthalmology 102 (1995) 1578-1579
88. Matsumoto J.C., and Chu Y.S.R. Epi-LASIK update: overview of techniques and patient management. Int Ophthalmol Clin 46 (2006) 105-115
89. McDermott M.L., Wang J., and Shin D.H. Mitomycin and the human corneal endothelium. Arch Ophthalmol 112 (1994) 533-537
90. Midena E., Gambato C., Miotto S., et al. Long-term effects on corneal keratocytes of mitomycin C during photorefractive keratectomy: a randomized contralateral eye confocal microscopy study. J Refract Surg 23 (2007) S1011-S1014
91. Mietz H., Addicks K., Diestelhorst M., and Krieglstein G.K. Extraocular application of mitomycin C in a rabbit model: cytotoxic effects on the ciliary body and epithelium. Ophthalmic Surg 25 (1994) 240-244
92. Mietz H., Roters S., and Krieglstein G.K. Bullous keratopathy as a complication of trabeculectomy with mitomycin C. Graefes Arch Clin Exp Ophthalmol 243 12 (2005) 1284-1287
93. Mirza M.A., Qazi M.A., and Pepose J.S. Treatment of dense subepithelial corneal haze after laser-assisted subepithelial keratectomy. J Cataract Refract Surg 30 (2004) 709-714
94. Mladenov E., Tsaneva I., and Anachkova B. Activation of the S phase DNA damage checkpoint by mitomycin C. J Cell Physiol 211 (2007) 468-476
95. Moilanen J.A., Vesaluoma M.H., Muller L.J., and Tervo T.M. Long-term corneal morphology after PRK by in vivo confocal microscopy. Invest Ophthalmol Vis Sci 44 (2003) 1064-1069
96. Moller-Pedersen T., Cavanagh H.D., Petroll W.M., and Jester J.V. Corneal haze development after PRK is regulated by volume of stromal tissue removal. Cornea 17 (1998) 627-639
97. Moller-Pedersen T., Cavanagh H.D., Petroll W.M., and Jester J.V. Stromal wound healing explains refractive instability and haze development after photorefractive keratectomy. A 1-year confocal microscopic study. Ophthalmology 107 (2000) 1235-1245
98. Moller-Pedersen T. Keratocyte reflectivity and corneal haze. Exp Eye Res 78 (2004) 553-560
99. Morales A.J., Zadok D., Mora-Retana R., et al. Intraoperative mitomycin and corneal endothelium after photorefractive keratectomy. Am J Ophthalmol 142 (2006) 400-404
100. Müller L.T., Candal E.M., Epstein R.J., et al. Transepithelial phototherapeutic keratectomy/photorefractive keratectomy with adjunctive mitomycin-C for complicated LASIK flaps. J Cataract Refract Surg 31 (2005) 291-296
101. Nagy Z.Z., Hiscott P., Seitz B., et al. Clinical and morphological response to UV-B irradiation after excimer laser photorefractive keratectomy. Surv Ophthalmol 42 (1997) S64-S76
102. Nassaralla B.A., McLeod S.D., and Nassaralla J.J. Prophylactic mitomycin C to inhibit corneal haze after residual myopia following radial keratotomy. J Refract Surg 23 (2007) 226-232
103. Nassiri N., Farahangiz S., Rahnavardi M., et al. Corneal endothelial cell injury induced by mitomycin-C in photorefractive keratectomy: nonrandomized controlled trial. J Cataract Refract Surg 34 (2008) 902-908
104. Netto M.V., Barreto J., Santo R., et al. Synergistic effect of ethanol and mitomycin C on corneal stroma. J Refract Surg 24 (2008) 626-632
105. Netto M.V., Chalita M.R., and Krueger R.R. Corneal haze following PRK with mitomycin C as a retreatment versus prophylactic use in the contralateral eye. J Refract Surg 23 (2007) 96-98
106. Netto M.V., Mohan R.R., Ambrosio R., et al. Wound healing in the cornea. A review of refractive surgery complications and new prospects for therapy. Cornea 24 (2005) 509-522
107. Netto M.V., Mohan R.R., Sinha S., et al. Effect of prophylactic and therapeutic mitomycin C on corneal apoptosis, cellular proliferation, haze, and long-term keratocyte density in rabbits. J Refract Surg 22 (2006) 562-574
108. Netto M.V., and Wilson S.E. Indications for excimer laser surface ablation. J Refract Surg 21 (2005) 734-741
109. Nuyts R.M., Felten P.C., Pels E., et al. Histopathologic effects of mitomycin C after trabeculectomy in human glaucomatous eyes with persistent hypotony. Am J Ophthalmol 118 (1994) 225-237
110. Nuyts R.M., Pels E., and Greve E.L. The effects of 5-fluorouracil and mitomycin C on the corneal endothelium. Curr Eye Res 11 (1992) 565-570
111. O'Brart D.P., Patsoura E., Jaycock P., et al. Excimer laser photorefractive keratectomy for hyperopia: 7.5-year follow-up. J Cataract Refract Surg 31 (2005) 1104-1113
112. O'Brart D.P.S., Mellington F., Jones S., and Marshall J. Laser epithelial keratomileusis for the correction of hyperopia using a 7.0-mm optical zone with the Schwind ESIRIS laser. J Refract Surg 23 (2007) 343-354
113. O'Doherty M., Kirwan C., O'Keeffe M., and O'Doherty J. Postoperative pain following epi-LASIK, LASEK, and PRK for myopia. J Refract Surg 23 (2007) 133-138
114. Occleston N.L., Daniels J.T., Tarnuzzer R.W., et al. Single exposures to antiproliferatives: long-term effects on ocular fibroblast wound-healing behaviour. Invest Ophthalmol Vis Sci 38 (1997) 1998-2007
115. Panda A., Peer J., Aggarwal A., et al. Effect of topical mitomycin C on corneal endothelium. Am J Ophthalmol 145 (2008) 635-638
116. Perez-Santonja J.J., Sahla H.F., and Alio J.L. Evaluation of endothelial cells changes one year after excimer laser in situ keratomileusis. Arch Ophthalmol 115 (1997) 841-846
117. Pfister R.R. Permanent corneal edema resulting from the treatment of PTK corneal haze with mitomycin: a case report. Cornea 23 (2004) 744-747
118. Pietilä J., Mäkinen P., and Uusitalo H. Repeated photorefractive keratectomy for undercorrection and regression. J Refract Surg 18 (2002) 155-161
119. Pogrebniak H.W., Matthews W., and Pass H.I. Chemotherapy amplifies production of tumor necrosis factor. Surgery 110 (1991) 231-237
120. Porges Y., Beh-Haim O., Hirsh A., and Levinger S. Phototherapeutic keratectomy with mitomycin C for corneal haze following photorefractive keratectomy for myopia. J Refract Surg 19 (2003) 40-43
121. Pritsos C.A., and Sartorelli A.C. Generation of reactive oxygen radicals through bioactivation of mitomycin antibiotics. Cancer Res 46 (1986) 3528-3532
122. Qazi M.A., Johnson T.W., and Pepose J.S. Development of late-onset subepithelial corneal haze after laser-assisted subepithelial keratectomy with prophylactic intraoperative mitomycin-C. Case report and literature review. J Cataract Refract Surg 32 (2006) 1573-1578
123. Rajan M.S., O'Brart D.P.S., Patmore A., and Marshall J. Cellular effects of mitomycin-C on human corneas after photorefractive keratectomy. J Cataract Refract Surg 32 (2006) 1741-1747
124. Rajan M.S., Watters W., Patmore A., and Marshall J. In vitro human corneal model to investigate stromal epithelial interactions following refractive surgery. J Cataract Refract Surg 31 (2005) 1789-1801
125. Rang H.P., and Dale M.M. Quimioterapia anticancerígena, in Rang HP, Dale MM. Farmacología (1995), Churchill Livingstone, Madrid ed 2; pp 846-70
126. Ribeiro J.C., McDonald M.B., Lemos M.M., et al. Excimer laser photorefractive keratectomy after radial keratotomy. J Refract Surg 11 (1995) 165-169
127. Rockwell S., and Kim S.Y. Cytotoxic potential of monoalkylation products between mitomycins and DNA: studies of decarbamoyl mitomycin C in wild-type and repair-deficient cell lines. Oncol Res 7 (1995) 39-47
128. Roh D.S., Cook A.L., Rhee S.S., et al. DNA cross-linking, double-strand breaks and apoptosis in corneal endothelial cells after a single exposure to mitomycin-C. Invest Ophthalmol Vis Sci 49 11 (2008) 4837-4843
129. Rozsíval P., and Feuermannová A. Retreatment after photorefractive keratectomy for low myopia. Ophthalmology 105 (1998) 1189-1192
130. Sadeghi H.M., Seitz B., Hayashi S., et al. In vitro effects of mitomycin C on human keratocytes. J Refract Surg 14 (1998) 534-540
131. Sari A., Onol M., Ozdek S., et al. Effect of mitomycin C on ciliary body and intraocular pressure with various application depths: an experimental study. Clin Experiment Ophthalmol 33 (2005) 169-175
132. Schipper I., Suppelt C., and Gebbers J.O. Mitomycin C reduces scar formation after excimer laser (193 nm) photorefractive keratectomy in rabbits. Eye 11 (1997) 649-655
133. Schraermeyer U., Diestelhorst M., Bieker A., et al. Morphologic proof of the toxicity of mitomycin C on the ciliary body in relation to different application methods. Graefes Arch Clin Exp Ophthalmol 237 (1999) 593-600
134. Senoo T., and Joyce N.C. Cell cycle kinetics in corneal endothelium from old and young donors. Invest Ophthalmol Vis Sci 41 (2000) 660-667
135. Seong G.J., Park C., Kim C.Y., et al. Mitomycin-C induces the apoptosis of human Tenon's capsule fibroblast by activation of c-Jun N-terminal kinase 1 and caspase-3 protease. Invest Ophthalmol Vis Sci 46 (2005) 3545-3552
136. Shah S., Doyle S.J., Chatterjee A., et al. Comparison of 18% ethanol and mechanical debridement for epithelial removal before photorefractive keratectomy. J Refract Surg 14 (1998) S212-S214
137. Shah S., Sarhan A.R.S., Doyle S.J., et al. The epithelial flap for photorefractive keratectomy. Br J Ophthalmol 85 (2001) 393-396
138. Shaikh N.M., Wee C.E., and Kaufman S.C. The safety and efficacy of photorefractive keratectomy after laser in situ keratomileusis. J Refract Surg 21 (2005) 353-358
139. Skolnick A.C., and Grimmett M.R. Management of pterygium. In: Krachmer J.H., Mannis M.J., and Holland E.J. (Eds). Cornea. ed 2. (2005), Elsevier Mosby, Philadelphia, PA 1873-1892
140. Smith S., D'Amore P.A., and Dreyer E.B. Comparative toxicity of mitomycin C and 5-fluorouracil in vitro. Am J Ophthalmol 118 (1994) 332-337
141. Solomon R., Donnenfeld E.D., and Perry H.D. Photorefractive keratectomy with mitomycin C for the management of a LASIK flap complication following a penetrating keratoplasty. Cornea 20 (2004) 403-405
142. Solomon R., Donnenfeld E.D., Thimons J., et al. Hyperopic photorefractive keratectomy with adjunctive topical mitomycin C for refractive error after penetrating keratoplasty for keratoconus. Eye Contact Lens 30 (2004) 156-158
143. Song J.S., Kim J.H., Yang M., et al. Concentrations of mitomycin C in rabbit corneal tissue and aqueous humor after topical administration. Cornea 25 (2006) S20-S23
144. Song J.S., Kim J.H., Yang M., et al. Mitomycin C concentration in cornea and aqueous humor and apoptosis in the stroma after topical Mitomycin-C application. Effects of Mitomycin-C application time and concentration. Cornea 26 (2007) 461-467
145. Spadea L., Sabetti L., D'Alessandri L., and Balestrazzi E. Photorefractive keratectomy and LASIK for the correction of hyperopia: 2-year follow-up. J Refract Surg 22 (2006) 131-136
146. Srinivasan S., Drake A., and Herzig S. Photorefractive keratectomy with 0.02% mitomycin C for treatment of residual refractive errors after LASIK. J Refract Surg 24 (2008) S64-S67
147. Steinert R.F., Ashrafzadeh A., and Hersh P.S. Results of phototherapeutic keratectomy in the management of flap striae after LASIK. Ophthalmology 111 (2004) 740-746
148. Stojanovic A., and Nitter T.A. Correlation between ultraviolet radiation level and the incidence of late-onset corneal haze after photorefractive keratectomy. J Cataract Refract Surg 27 (2001) 404-410
149. Tabbara K.F., El-Sheikh H.F., Sharara N.A., and Aabed B. Corneal haze among blue eyes and brown eyes after photorefractive keratectomy. Ophthalmology 106 (1999) 2210-2215
150. Talamo J.H., Gollamudi S., Green W.R., et al. Modulation of corneal wound healing after excimer laser keratomileusis using topical mitomycin C and steroids. Arch Ophthalmol 109 (1991) 1141-1146
151. Taneri S., Feit R., and Azar D.T. Safety, efficacy and stability indices of LASEK correction in moderate myopia and astigmatism. J Cataract Refract Surg 30 (2004) 2130-2137
152. Taneri S., Koch J.M., Melki S.A., and Azar D.T. Mitomycin-C assisted photorefractive keratectomy in the treatment of buttonholed laser in situ keratomileusis flaps associated with epithelial ingrowth. J Cataract Refract Surg 31 (2005) 2026-2030
153. Taneri S., Zieske J.D., and Azar D.T. Evolution, techniques, clinical outcomes and pathophysiology of LASEK: Review of the literature. Surv Ophthalmol 49 6 (2004) 576-602
154. Teus M.A., de Benito-Llopis L., and Sánchez-Pina J.M. LASEK versus LASIK for the correction of moderate myopia. Optom Vis Sci 84 (2007) 605-610
155. Teus M.A., and de Benito-Llopis L. LASEK with MMC to treat post-LASIK myopic regression. J Cataract Refract Surg 33 (2007) 1674-1675
156. Thornton I., Puri A., Xu M., and Krueger R.R. Low-dose mitomycin C as a prophylaxis for corneal haze in myopic surface ablation. Am J Ophthalmol 144 (2007) 673-681
157. Thornton I., Xu M., and Krueger R.R. Comparison of standard (0.02%) and low dose (0.002%) mitomycin C in the prevention of corneal haze following surface ablation for myopia. J Refract Surg 24 (2008) S68-S76
158. Torres R.M., Merayo-Lloves J., Daya S.M., et al. Presence of mitomycin-C in the anterior chamber after photorefractive keratectomy. J Cataract Refract Surg 32 (2006) 67-71
159. Trattler W., and Salz J.J. Surface ablation over LASIK flaps. Int Ophthalmol Clin 46 (2006) 117-122
160. Varley G.A., Huang D., Rapuano C.J., et al. LASIK for hyperopia, hyperopic astigmatism, and mixed astigmatism. A report by the American Academy of Ophthalmology. Ophthalmology 111 (2004) 1604-1617
161. Verweij J., and Pinedo H.M. Mitomycin C: mechanism of action, usefulness and limitations. Anticancer Drugs 1 (1990) 5-13
162. Vigo L., Scandola E., and Carones F. Scraping and mitomycin C to treat haze and regression after photorefractive keratectomy for myopia. J Refract Surg 19 (2003) 449-454
163. Wallau A.D., and Campos M. Photorefractive keratectomy with mitomycin C versus LASIK in custom surgeries for myopia: a bilateral prospective randomized clinical trial. J Refract Surg 24 (2008) 326-336
164. Wang S.L., Han J.F., He X.Y., et al. Genetic variation of human cytochrome p450 reductase as a potential biomarker for mitomycin C-induced cytotoxicity. Drug Metab Dispos 35 (2007) 176-179
165. Weisenthal R.W., Salz J., Sugar A., et al. Photorefractive keratectomy for treatment of flap complications in laser in situ keratomileusis. Cornea 22 (2003) 399-404
166. Wu K.Y., Hong S.J., Huang H.T., et al. Toxic effects of mitomycin-C on cultured corneal keratocytes and endothelial cells. J Ocul Pharmacol Ther 15 (1999) 401-411
167. Xu H., Liu S., Xia X., et al. Mitomycin C reduces haze formation in rabbits after excimer laser photorefractive keratectomy. J Refract Surg 17 (2001) 342-349
168. Yee R.W., and Yee S.B. Update on laser subepithelial keratectomy (LASEK). Curr Opin Ophthalmol 15 (2004) 333-341
169. Zhao L.Q., Wei R.L., Ma X.Y., and Zhu H. Effect of intraoperative mitomycin-C on healthy corneal endothelium after laser-assisted subepithelial keratectomy. J Cataract Refract Surg 34 (2008) 1715-1719